MyFinsight
Home
Blog
About
Short-term investments
$94,365,000
Cash and cash
equivalents
$8,267,000
Prepaid expenses and
other current assets
$3,461,000
Accrued interest
receivable
$1,844,000
Total property, plant
and equipment,...
$32,981,000
Total current assets
$107,937,000
Long-term investments
$105,346,000
Property, plant and
equipment, net
$14,229,000
Long-term prepaid assets
$5,344,000
Financing lease
right-of-use assets
$3,453,000
Operating lease
right-of-use assets
$1,901,000
Less accumulated
depreciation and...
$18,752,000
Total assets
$238,210,000
Total liabilities and
stockholders' equity
$238,210,000
Total stockholders'
equity
$214,785,000
Total liabilities
$23,425,000
Accumulated deficit
-$152,255,000
Treasury stock, at cost
54,665 shares held at...
$5,521,000
Accumulated other
comprehensive income (loss)
-$930,000
Additional paid-in capital
$373,483,000
Total current
liabilities
$11,705,000
Warrant liabilities
$7,229,000
Finance lease
liabilities, noncurrent
$3,040,000
Operating lease
liabilities, noncurrent
$1,451,000
Common stock 0.0001 par
value 800,000,000...
$8,000
Accrued expenses and
other current...
$7,209,000
Accounts payable
$3,855,000
Operating lease
liabilities, current portion
$481,000
Finance lease
liabilities, current portion
$160,000
Back
Back
Balance Sheet
SAB Biotherapeutics, Inc. (SABSW)
SAB Biotherapeutics, Inc. (SABSW)
source: myfinsight.com